Biology and clinical management of hypoplastic MDS: MDS as a bone marrow failure syndrome
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biology and clinical management of hypoplastic MDS: MDS as a bone marrow failure syndrome
Authors
Keywords
Hypoplastic MDS, Bone marrow failure, Biology, Clinical management
Journal
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
Volume 34, Issue 2, Pages 101280
Publisher
Elsevier BV
Online
2021-06-26
DOI
10.1016/j.beha.2021.101280
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hypoplastic Myelodysplastic Syndromes: Just an Overlap Syndrome?
- (2021) Bruno Fattizzo et al. Cancers
- Cancer spectrum and outcomes in the Mendelian short telomere syndromes
- (2020) Kristen E Schratz et al. BLOOD
- Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes
- (2020) Pierre Fenaux et al. NEW ENGLAND JOURNAL OF MEDICINE
- Eltrombopag monotherapy can improve hematopoiesis in patients with low to intermediate risk-1 myelodysplastic syndrome
- (2020) Alana Vicente et al. HAEMATOLOGICA
- Very long-term follow-up of aplastic anemia treated with immunosuppressive therapy or allogeneic hematopoietic cell transplantation
- (2020) Beatrice Drexler et al. ANNALS OF HEMATOLOGY
- Clinical, histopathological and molecular characterization of hypoplastic myelodysplastic syndrome
- (2019) Elisa Bono et al. LEUKEMIA
- Clinical Outcomes of Decitabine Treatment for Patients With Lower-Risk Myelodysplastic Syndrome on the Basis of the International Prognostic Scoring System
- (2019) Ki Sun Jung et al. Clinical Lymphoma Myeloma & Leukemia
- Long-term outcome of a randomized controlled study in patients with newly diagnosed severe aplastic anemia treated with antithymocyte globuline, cyclosporine, with or without G-CSF: a Severe Aplastic Anemia Working Party Trial from the European Group of Blood and Marrow Transplantation
- (2019) André Tichelli et al. HAEMATOLOGICA
- Acquired and Germline Predisposition to Bone Marrow Failure: Diagnostic features and clinical implications
- (2018) Michael E. Kallen et al. SEMINARS IN HEMATOLOGY
- Long-term follow-up for up to 5 years on the risk of leukaemic progression in thrombocytopenic patients with lower-risk myelodysplastic syndromes treated with romiplostim or placebo in a randomised double-blind trial
- (2018) Hagop M Kantarjian et al. Lancet Haematology
- What biologic factors predict for transformation to AML?
- (2018) Rafael Bejar BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Macrophage TNF-α licenses donor T cells in murine bone marrow failure and can be implicated in human aplastic anemia
- (2018) Wanling Sun et al. BLOOD
- Azacitidine with or without eltrombopag for first-line treatment of intermediate- or high-risk MDS with thrombocytopenia
- (2018) Michael Dickinson et al. BLOOD
- Pathogenesis of Acquired Aplastic Anemia and the Role of the Bone Marrow Microenvironment
- (2018) Michael Medinger et al. Frontiers in Oncology
- DNA repair gene expressions are related to bone marrow cellularity in myelodysplastic syndrome
- (2017) Howard L Ribeiro et al. JOURNAL OF CLINICAL PATHOLOGY
- Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia
- (2017) Danielle M. Townsley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial
- (2017) Esther N Oliva et al. Lancet Haematology
- How I treat MDS and AML in Fanconi anemia
- (2016) R. Peffault de Latour et al. BLOOD
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
- (2016) D. A. Arber et al. BLOOD
- Bone marrow transplantation versus immunosuppressive therapy in patients with acquired severe aplastic anemia
- (2016) Andrea Bacigalupo et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS)
- (2016) Chi-Yuan Yao et al. Oncotarget
- SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts
- (2015) L. Malcovati et al. BLOOD
- Genomic patterns associated with hypoplastic compared to hyperplastic myelodysplastic syndromes
- (2015) A. Nazha et al. HAEMATOLOGICA
- Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia
- (2015) Tetsuichi Yoshizato et al. NEW ENGLAND JOURNAL OF MEDICINE
- Emergence of clonal hematopoiesis in the majority of patients with acquired aplastic anemia
- (2015) Daria V. Babushok et al. Cancer Genetics
- Genomic patterns associated with hypoplastic compared to hyperplastic myelodysplastic syndromes
- (2015) A. Nazha et al. HAEMATOLOGICA
- Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R
- (2014) M. G. Della Porta et al. BLOOD
- Bone marrow failure and the telomeropathies
- (2014) D. M. Townsley et al. BLOOD
- Paroxysmal nocturnal hemoglobinuria
- (2014) R. A. Brodsky BLOOD
- Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome
- (2014) A. G. Kulasekararaj et al. BLOOD
- Bone marrow hypocellularity does not affect tolerance or efficacy of azacitidine in patients with higher-risk myelodysplastic syndromes
- (2014) John F. Seymour et al. BRITISH JOURNAL OF HAEMATOLOGY
- Results of a randomized, double-blind study of romiplostim versus placebo in patients with low/intermediate-1-risk myelodysplastic syndrome and thrombocytopenia
- (2014) Aristoteles Giagounidis et al. CANCER
- Detection of paroxysmal nocturnal hemoglobinuria clones to exclude inherited bone marrow failure syndromes
- (2014) Amy E. DeZern et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Impact of genomic damage and ageing on stem cell function
- (2014) Axel Behrens et al. NATURE CELL BIOLOGY
- Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
- (2014) Siddhartha Jaiswal et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Challenging World of Cytopenias: Distinguishing Myelodysplastic Syndromes From Other Disorders of Marrow Failure
- (2014) Amy E. DeZern et al. ONCOLOGIST
- Limited clinical efficacy of azacitidine in transfusion-dependent, growth factor-resistant, low- and Int-1-risk MDS: Results from the nordic NMDSG08A phase II trial
- (2014) M Tobiasson et al. Blood Cancer Journal
- Can the revised IPSS predict response to erythropoietic-stimulating agents in patients with classical IPSS low or intermediate-1 MDS?
- (2013) V. Santini et al. BLOOD
- Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug
- (2013) R. Desmond et al. BLOOD
- Burst-forming unit–erythroid assays to distinguish cellular bone marrow failure disorders
- (2013) Amy E. DeZern et al. EXPERIMENTAL HEMATOLOGY
- Impaired clearance of apoptotic cells leads to HMGB1 release in the bone marrow of patients with myelodysplastic syndromes and induces TLR4-mediated cytokine production
- (2013) M. Velegraki et al. HAEMATOLOGICA
- Role of Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem-Cell Transplantation in Older Patients With De Novo Myelodysplastic Syndromes: An International Collaborative Decision Analysis
- (2013) John Koreth et al. JOURNAL OF CLINICAL ONCOLOGY
- Low frequency clonal mutations recoverable by deep sequencing in patients with aplastic anemia
- (2013) A A Lane et al. LEUKEMIA
- IL10 inversely correlates with the percentage of CD8+ cells in MDS patients
- (2013) Matheus Rodrigues Lopes et al. LEUKEMIA RESEARCH
- Proteins related to the spindle and checkpoint mitotic emphasize the different pathogenesis of hypoplastic MDS
- (2013) Fabiola Fernandes Heredia et al. LEUKEMIA RESEARCH
- Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations
- (2012) B. Will et al. BLOOD
- Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis
- (2012) A. Jerez et al. BLOOD
- Revised International Prognostic Scoring System for Myelodysplastic Syndromes
- (2012) P. L. Greenberg et al. BLOOD
- Chronic inflammation and aging: DNA damage tips the balance
- (2012) Mary M Cavanagh et al. CURRENT OPINION IN IMMUNOLOGY
- Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group
- (2012) T M Westers et al. LEUKEMIA
- Eltrombopag and Improved Hematopoiesis in Refractory Aplastic Anemia
- (2012) Matthew J. Olnes et al. NEW ENGLAND JOURNAL OF MEDICINE
- The use of selective immunosuppressive therapy on myelodysplastic syndromes in targeted populations results in good response rates and avoids treatment-related disease progression
- (2011) Li Xiao et al. AMERICAN JOURNAL OF HEMATOLOGY
- Immunosuppressive therapies in the management of acquired immune-mediated marrow failures
- (2011) Antonio M. Risitano CURRENT OPINION IN HEMATOLOGY
- Long-term follow up after allogeneic stem cell transplantation in patients with severe aplastic anemia after cyclophosphamide plus antithymocyte globulin conditioning
- (2011) J. Konopacki et al. HAEMATOLOGICA
- Impact of Immunogenetic Polymorphisms in Bone Marrow Failure Syndromes
- (2011) B. Serio et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia
- (2011) Christopher N Hahn et al. NATURE GENETICS
- Pathophysiology and management of inherited bone marrow failure syndromes
- (2010) Akiko Shimamura et al. BLOOD REVIEWS
- Azacitidine for the treatment of lower risk myelodysplastic syndromes
- (2010) Pellegrino Musto et al. CANCER
- Comparison of Immunological Abnormalities of Lymphocytes in Bone Marrow in Myelodysplastic Syndrome (MDS) and Aplastic Anemia (AA)
- (2010) Xiao Li et al. INTERNAL MEDICINE
- Immunosuppressive Therapy for Patients With Myelodysplastic Syndrome: A Prospective Randomized Multicenter Phase III Trial Comparing Antithymocyte Globulin Plus Cyclosporine With Best Supportive Care—SAKK 33/99
- (2010) Jakob R. Passweg et al. JOURNAL OF CLINICAL ONCOLOGY
- Hypoplastic myelodysplastic syndrome (h-MDS) is a distinctive clinical entity with poorer prognosis and frequent karyotypic and FISH abnormalities compared to aplastic anemia (AA)
- (2010) Youngil Koh et al. LEUKEMIA RESEARCH
- Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia
- (2009) D. C. Vinh et al. BLOOD
- Prevalence of mutations inELANE,GFI1,HAX1,SBDS,WASandG6PC3in patients with severe congenital neutropenia
- (2009) Jun Xia et al. BRITISH JOURNAL OF HAEMATOLOGY
- Immune dysregulation and dyserythropoiesis in the myelodysplastic syndromes
- (2009) Fiorella Alfinito et al. BRITISH JOURNAL OF HAEMATOLOGY
- Diagnostic criteria to distinguish hypocellular acute myeloid leukemia from hypocellular myelodysplastic syndromes and aplastic anemia: recommendations for a standardized approach
- (2009) J. M. Bennett et al. HAEMATOLOGICA
- Hematopoietic growth factors in aplastic anemia patients treated with immunosuppressive therapy-systematic review and meta-analysis
- (2009) R. Gurion et al. HAEMATOLOGICA
- Safety and Efficacy of Romiplostim in Patients With Lower-Risk Myelodysplastic Syndrome and Thrombocytopenia
- (2009) Hagop Kantarjian et al. JOURNAL OF CLINICAL ONCOLOGY
- The ambiguous role of interferon regulatory factor-1 (IRF-1) immunoexpression in myelodysplastic syndrome
- (2009) Ronald Feitosa Pinheiro et al. LEUKEMIA RESEARCH
- Telomere Diseases
- (2009) Rodrigo T. Calado et al. NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started